|
NTRA | Natera, Inc. |
|
|
NTRA | Natera, Inc. |
| Services-Medical Laboratories |
| Book value per $ invested | $ 0.06 |
| Leverage | 28.02% |
| Market Cap | $ 20.9B |
| PE | 0.00 |
| Dividend Yield | 0.00% |
| Profit | $ -189.3m |
| Margin | -11.22% |
Natera, Inc., a diagnostic company, develops and markets molecular testing services globally. The company is headquartered in San Carlos, California.